October 2025 Review and Outlook

U.S. equities, driven by large-cap growth and the "Magnificent Seven," achieved record highs in October, despite a narrowing market breadth where value and mid-cap indices lagged. The Federal Reserve implemented a 25 basis-point rate cut but surprised markets with a hawkish tone, leading to a repricing of December rate cut expectations. This performance was supported by robust Q3 S&P 500 earnings, which grew 10.7% year-over-year, easing U.S.-China trade tensions, and strong sector-specific gains in technology and semiconductors, all contributing to a constructive year-end outlook bolstered by historical seasonal tailwinds.

Analysis

U.S. equities achieved record highs in October, with the S&P 500 gaining 2.3% and the Nasdaq-100 surging 4.8%, primarily driven by large-cap growth stocks and the "Magnificent Seven" (+4.9%). This strong performance was underpinned by robust Q3 S&P 500 earnings, which recorded a 10.7% year-over-year growth, significantly exceeding the 7.9% expectation. Easing U.S.-China trade tensions also contributed to investor sentiment, providing a temporary reprieve from geopolitical uncertainty.

However, market breadth narrowed considerably, with the S&P 500 Equal Weight index declining 0.9% and the S&P Midcap 400 falling 0.5%, indicating a concentrated rally. The Federal Reserve's 25 basis-point rate cut was overshadowed by Chair Powell's "strongly hawkish tone," which unexpectedly repriced the probability of a December rate cut from 90% to 60%, introducing monetary policy uncertainty.

Sector performance was bifurcated, with Technology (+6.2%) and Healthcare (+3.6%) leading, particularly semiconductors (SOX Index +13.5%) and small-cap biotech (+10%). Conversely, Materials (-5%) and Financials (-2.8%) lagged, reflecting specific credit concerns. Despite the elevated forward 12-month P/E ratio of 22.9 for the S&P 500, historical seasonality suggests a constructive outlook, with November and December being historically strong months for equities.

Key Decisions for Investors

• Maintain strategic exposure to leading growth sectors like Technology and Healthcare, particularly semiconductors and biotech, given robust earnings and strong momentum.
• Re-evaluate interest rate sensitivity in portfolios following the Federal Reserve's hawkish shift, which has repriced expectations for future rate cuts.
• Monitor market breadth for potential rotation into lagging segments such as mid-cap and value stocks, as their underlying technical uptrends suggest potential for future catch-up.
• Be aware of the S&P 500's elevated forward P/E of 22.9 relative to historical averages, suggesting a need for selective investment despite positive seasonal tailwinds.